Aerie Pharmaceuticals, Inc.
(NASDAQ GM: AERI)
Rigrodsky Law, P.A. is investigating Aerie Pharmaceuticals, Inc. (“Aerie”) regarding possible breaches of fiduciary duties and other violations of law related to Aerie’s agreement to be acquired by Alcon Inc. Under the terms of the agreement, Aerie’s shareholders will receive $15.25 in cash for each share of Aerie common stock they own.